The board of directors at Immunic Therapeutics has a history of experience in the biotech industry and a variety of educational backgrounds. The current CEO, Curexsys, has a background in Biotechnology from the Massachusetts Institute of Technology. Other board members include Imcyse SA, ViCentra, and Kuros Biosciences. These members have a variety of educational backgrounds including Biotechnology, Economics, and more.
View all